Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Upcoming Topics

Essential Evidence Plus (EE+) was designed around a validated scheme for classifying the questions of physicians. The Editor in Chief, Dr Mark Ebell and colleagues originally identified 57 generic types of questions, such as "What is the best drug x for disease y?"1 Dr Ebell collapsed some of those categories into the current scheme for EE+, to assure that all of the key questions of a practicing physician are addressed by each EE+ topic.2 The original topic list of 800 topics was based on a review of the most common conditions seen by primary care doctors based on the US National Ambulatory Medical Care Survey, and a careful review of the tables of contents of standard medical references.

1. Ely JW, Osheroff JA, Ebell MH, Bergus GR, Levy BT, Chambliss ML, Evans ER. Analysis of questions asked by family doctors regarding patient care. BMJ. 1999 Aug 7;319(7206):358-61.
2. Ely JW, Osheroff JA, Gorman PN, Ebell MH, Chambliss ML, Pifer EA, Stavri PZ. A taxonomy of generic clinical questions: classification study. BMJ. 2000 Aug 12;321(7258):429-32.

If there is a topic area that is not already listed in EE+ that you feel would benefit the research community then please contact Georgina Smith ([email protected]) with your suggestion for a new topic. Please provide us with your CV, a brief justification of relevance to the research community along with any names of potential co-authors for this new topic. The proposal will be considered by our Editor-in-Chief, Professor Mark Ebell, and if approved we will support you through the rest of the process. We look forward to hearing your ideas!

The following topics represent those that we intend to develop in the future:

High priority topics

  • Acid-based abnormalities
  • Bronchopulmonary dysplasia
  • Gastric outlet obstruction
  • Hepatomegaly
  • Histiocytosis
  • Leukemia (chronic lymphocytic)

Lower priority topics

  • African tick-bite fever
  • Amyloidosis
  • Angioedema
  • Apnea (neonatal)
  • Ataxia (diagnosis)
  • Atrial and ventricular septal defects
  • Bronchiolitis obliterans
  • Congenital heart disease
  • Cysticercosis
  • Dacryocystitis
  • Dysphagia
  • Dystonic reaction
  • Echinococcosis
  • Endophthalmitis
  • Erythroblastosis fetalis
  • Floppy infant syndrome
  • Fracture (hip and pelvis)
  • Fracture (nasal and facial)
  • Hernia (diaphragmatic)
  • Hernia (femoral)
  • Horner's syndrome
  • Injection (deltoid bursa)
  • Intussusception
  • Learning disabilities (child)
  • Methemoglobinemia
  • Nephrotic syndrome
  • Rhesus isoimmunization
  • Rickettsial pox
  • Spinal tumors
  • Subphrenic abscess
  • Teratoma
  • Tracheitis
  • Trichinosis
  • Wiskott-Aldrich syndrome